Belvedere Trading
CRBU icon

Belvedere Trading’s Caribou Biosciences CRBU Stock Holding History

Belvedere Trading’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,429
Closed -$83.3K – 837
2023
Q3 		$83.3K Buy
17,429
+2,330
+15% +$14.5K ﹤0.01% 362
2023
Q2 		$64.2K Buy
+15,099
New +$67.8K ﹤0.01% 510

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Belvedere Trading's CRBU Position: Q4 2023 in Review

Belvedere Trading sold out of Caribou Biosciences (CRBU) in Q4 2023, closing a stake of 17,429 shares — an estimated $83.3K sold.

Belvedere Trading first reported a position in CRBU in Q2 2023 and held it in 2 quarters. The position peaked at $83.3K in Q3 2023. 144 funds tracked by Wall St. Rank hold CRBU as of Q4 2023.

  • Belvedere Trading reported no remaining Caribou Biosciences position as of Q4 2023 after selling out during the quarter.
  • Belvedere Trading sold 17,429 Caribou Biosciences shares in Q4 2023, an estimated $83.3K.
  • Belvedere Trading first reported a position in Caribou Biosciences in Q2 2023 and held it in 2 quarters.
  • Belvedere Trading's Caribou Biosciences position peaked at $83.3K in Q3 2023.
  • 144 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2023.

Based on Belvedere Trading's 13F filing for Q4 2023, filed 13 Feb 2024.